Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NPEPL1 Inhibitors

NPEPL1 inhibitors belong to a specific chemical class of compounds that target and inhibit the activity of the NPEPL1 enzyme. This class of inhibitors is designed to modulate the function of NPEPL1 by binding to its active site and disrupting its normal enzymatic activity. NPEPL1, also known as Aminopeptidase B, is a proteolytic enzyme found in various tissues and cells throughout the body. It plays a significant role in the breakdown and metabolism of peptides, particularly those involved in regulating various physiological processes.

By inhibiting NPEPL1, these inhibitors have the potential to influence peptide metabolism and thereby modulate cellular functions and signaling pathways associated with NPEPL1 activity. The precise mechanism of action of NPEPL1 inhibitors may vary depending on the specific compound, but their overall objective is to selectively inhibit the enzymatic activity of NPEPL1, leading to downstream effects on peptide metabolism. Understanding the molecular interactions between NPEPL1 and its inhibitors can provide valuable insights into the role of this enzyme in cellular processes and may contribute to the development of novel strategies for modulating peptide metabolism in a controlled manner.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bestatin

58970-76-6sc-202975
10 mg
$131.00
19
(3)

Bestatin is one of the first identified NPEPL1 inhibitors. It is a naturally occurring inhibitor and has been used as an anticancer drug. Bestatin inhibits NPEPL1 by binding to its active site and interfering with its enzymatic activity.